Schadel Christopher Ryan reported option exercise involving 2,467 derivative units of Z Squared Inc. on Oct 27, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
Chief Marketing Officer
Chief Marketing Officer
Filed Nov 13, 2026

Facts from the filing

Form 4 · Derivative, table II
Disclosed value
—Shares × reported price
Shares traded
2,467Restricted Stock Units
Price per share
Price unknownReported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
7,038Direct
Trade date
Oct 27, 2026Option exercise
Filed
Nov 13, 2026, 6:55 PM ET17-day reporting delay
Accession
0001185185-26-005411Code M · Transaction 401309
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Oct 27, 2026Option exercise2,467$0.00$0Trade 401308
2 transaction rows in this filing. Joint filers share the same rows.

Filing warnings

Notes recorded with this filing
2 warnings
delayed filingThe filing was reported 17 calendar days after the transaction date.
missing priceThe filing did not provide a usable price per share.

ZSQR price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
ZSQR · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 20, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago −28%1w ago −1.1%1d ago +11%
Returns since7d30d90d180d1y

Footnotes in full

F1: On April 27, 2026, pursuant to Section 3(b) of the reporting person's Executive Employment Agreement, dated April 27, 2026, the issuer granted the reporting person 9,868 restricted stock units ("RSUs") representing an annual bonus award with an aggregate grant-date fair market value of $150,000. The grant was previously reported on the reporting person's Form 4 filed on April 30, 2026. Each RSU represents a contingent right to receive one share of common stock upon vesting and has no expiration date. The RSUs vest in four equal quarterly installments of 2,467 RSUs over the one-year period commencing on April 27, 2026 (on each of July 27, 2026, October 27, 2026, January 27, 2027 and April 27, 2027), subject to the reporting person's continued employment with the issuer on each vesting date. F2: Represents the second quarterly vesting of the RSUs described in footnote 1, which vested on October 27, 2026. Each RSU was settled in one share of common stock for no consideration. F3: The number of derivative securities beneficially owned following the reported transaction includes 4,934 RSUs remaining from the April 27, 2026 grant described in footnote 1 and 2,104 RSUs remaining from the 2,806 RSUs granted to the reporting person on June 3, 2026 under the issuer's 2025 Incentive Compensation Plan as a supplemental award in respect of the annual bonus under Section 3(b) of the reporting person's Executive Employment Agreement, previously reported on the reporting person's Form 4 filed on June 8, 2026 and the reporting person's Form 4/A filed on October 2, 2026. The June 3, 2026 RSUs vest in four substantially equal quarterly installments (subject to rounding) on each of September 3, 2026, December 3, 2026, March 3, 2027 and June 3, 2027, subject to continued employment on each vesting date.